Introduction
can be applied on a thick gel like structure known as mucin, therefore all bio-adhesives must interact with the mucin layer during the process of attachment, these represent the potential sites for attachment of any bioadhesive system wet tissue, are formulated by utilizing the adhesive properties of some water -soluble polymers. The mucosal layer lines a number of regions of the body including the gastrointestinal tract, buccal cavity, airways, ear, nose, eye, urogenital tract, vagina and rectum are covered [3] .
Acarbose is an oral ɑ-glucosidase inhibitor and used in the management of type II diabetes mellitus. Acarbose inhibits enzymes glycoside hydrolases needed to digest carbohydrates, specifically, ɑ-glucosidase enzyme in the brush border of the small intestines and pancreatic ɑ-amylase. Pancreatic ɑ-amylase hydrolyzes complex starch to oligosaccharides in the lumen of the small intestine, whereas the membrane-bound intestinal ɑ-glucosidases hydrolyze oligosaccharides, disaccharides and trisaccharides to glucose and other monosaccharides in the small intestine. Inhibition of these enzymes systems reduces the rate of digestion of complex carbohydrates [4] .
Materials and Methods
The drug Acarbose was obtained from Amol Pharmaceutical Pvt. Ltd. Ethyl cellulose and HPMC K15M and xanthan gum, guar gums were obtained from Central drug house. All other chemicals/reagents used were of analytical grade and were used as received. A UV/Vis spectrophotometer (UV-1800/Schimadzu) was used for drug analysis.
Preparation of microspheres
Mucoadhesive microspheres of Acarbose were prepared by emulsion solvent evaporation techniques. Drug and polymer were accurately weighed and mixed properly. This mixture is mixed in the solvent (DCM: Methanol: 1:1) at various ratios according to Table 1 . This slurry introduced into 250 ml beaker containing 40 ml of liquid paraffin in presence of 0.2% SLS solution and subsequently stirred at ranging agitation speed for 1 hr to allow the volatile solvent to evaporate. The floating microspheres were collected by decantation, washed thrice with n-hexane, dried overnight in oven at 40 ± 2°C and stored in desiccators [5] .
Characterization of mucoadhesive microspheres
Particle size analysis: The particle size was measured using an optical microscope, and the mean particle size was calculated by measuring 200 particles with the help of a calibrated ocular micrometer. A small amount of dry microspheres was suspended in purified water (10 ml). A small drop of suspension thus obtained was placed on a clean glass slide. The slide containing microspheres was mounted on the stage of the microscope and diameter of at least 100 particles was measured using a calibrated optical micrometer.
Drug content
The microspheres were powdered and suspended in phosphate buffer (pH 7.4). The resultant dispersion was kept for 20 min on the sonicator bath for uniform mixing and filtered through whatman filter paper. The filtrate obtained was examined using a UV visible spectrophotometer at 250 nm [6] .
Determination of incorporation efficiency
To determine the incorporation efficiency, 10 mg microspheres were thoroughly triturated and dissolved in minimum amount of methanol. The resulting solution was made up to 100 ml with 0.1 N HCl and filtered. Drug content was analyzed spectrophotometrically at 241.4 nm. The percentage incorporation efficiency and percentage drug loading were calculated [7] .
In vitro mucoadhesion test
In the present study, the eggshell membrane was used to substitute the animal stomach mucosa in the mucoadhesion evaluation of microspheres, based on the similarity between the eggshell membrane and the 
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stomach mucus with respect to its composition and thickness. The good correlation between in vitro data from the eggshell membrane and in vivo mucoadhesion studies demonstrated the potential of the eggshell membrane as substitute for the gastric mucosa.
The eggshell membranes were obtained from fresh chicken eggs. After emptying the egg of its content, the external shell was removed, and the underlying membrane was isolated. A piece of egg membrane was tied on to a glass slide. Approximately 50 microspheres were spread onto the wet membrane and the prepared slide was hung on one the groves of a USP tablet disintegrating test apparatus. The disintegrating test apparatus was operated such that membrane specimen was given regular up and down movements in a beaker containing the simulated gastric fluid USP (pH 6.8). At the end of 1, 5 and 10 h, the microspheres still adhering onto the membrane was counted [8] .
In vitro release of muchoadhesive microspheres
The drug release rate from mucoadhesive microspheres was determined using USP XXIII basket type dissolution apparatus. A weighed amount of floating microspheres equivalent to 20 mg Prazosin Hydrochloride was taken for dissolution study. Simulated gastric fluid (SGF, pH 0.1 N HCl) (900 ml) containing Tween 20 (0.02 w/v%) was used as the dissolution medium and maintained at 370°C at a rotation speed of 100 rpm. 5 ml sample was withdrawn at 1 hr interval and analyzed spectrophotometrically at 247 nm to determine the concentration of drug present in the dissolution medium. The initial volume of the dissolution fluid was maintained by adding 5 ml of fresh dissolution fluid after each withdrawal [9] . 
Results

Flow properties of Acarbose mucoadhesive microspheres
The prepared microspheres of Acarbose were evaluated for different micromeritic properties such as angle of repose, bulk density, tapped density, car`s index, hausner`s ratio etc. and the results of these flow properties are shown in Table 2 .
Physiochemical characteristic of mucoadhesive microspheres
The physiochemical characteristics of the prepared mucoadhesive microspheres of Acarbose are shown in Table 3 . The mucoadhesive microspheres were discrete and free flowing. The mean diameter varied between 105.5 to 413.5 µm. The yield of mucoadhesive microspheres was in the range of 63.5 to 83.2% which shows that the yield increased with the increased polymer concentration while drug entrapment efficiency ranged from 64.8 to 96.44%.
In vitro drug release
The drug release study from the prepared floating microspheres was performed using USP type-II apparatus (rotating paddle) in 900 ml of 0.1 N HCl dissolution media at 100 RPM at 37 ± 0.5°C for 12 hours. The in vitro release data of all the formulation of floating microspheres are tabulated in Tables 4-7 . Table 8 shows that some of microspheres were adhere to the membrane even after 8 hrs. The highest percentage mucoadhesion was found 14% in formulation.
In vitro mucoadhesion test
Conclusion
In the above study the mucoadhesive microspheres of Acarbose were prepared by emulsion solvent evaporation technique by using natural and natural polymers. It showed a high percentage of mucoadhesion and entrapment efficiency. The optimized formulation (C1) of Acarbose mucoadhesive microsphere prepared by natural polymer showed maximum drug release than the synthetic polymers and followed Higuchi release. Other evaluation parameters for natural polymer based mucoadhesive microsphere are higher than the synthetic. 
